DGAP-News: UMS AG: Final results confirm preliminary figures for 2010 - Management Board and Supervisory Board propose raising dividend to EUR0.50 per share - Forecast for 2011 is EUR0.60 to EUR0.70 per share


DGAP-News: UMS United Medical Systems International AG / Key word(s):
Final Results
UMS AG: Final results confirm preliminary figures for 2010 -
Management Board and Supervisory Board propose raising dividend to
EUR0.50 per share - Forecast for 2011 is EUR0.60 to EUR0.70 per share

04.04.2011 / 10:33

---------------------------------------------------------------------

Corporate News

UMS AG: Final results confirm preliminary figures for 2010 - Management
Board and Supervisory Board propose raising dividend to EUR0.50 per share -
Forecast for 2011 is EUR0.60 to EUR0.70 per share

Hamburg, 04.04.2011 - UMS United Medical Systems International AG (UMS/
ISIN DE0005493654) today released its certified figures (under IFRS) for
fiscal year 2010 that confirm the preliminary figures announced on March
18, 2011. Earnings per share improved significantly to EUR0.61 (2009:
EUR0.48).

The UMS Group's revenues again increased in fiscal year 2010, improving
from EUR35.7 million to EUR38.9 million. If the exchange rate effects are
ignored, revenues grew by 3%. In the UMS Group's largest business segment,
Urology, revenues grew by 6%.

EBIT at the Group level grew by 5% at constant exchange rates to EUR12.8
million, up from EUR11.5 million in the previous year. Consolidated profit
amounted to EUR10.0 million in fiscal year 2010; EUR3.1 million of this
amount was attributable to Group shareholders (2009: EUR2.6 million). As a
result, earnings per share reached EUR0.61, improving by around 20% over
the previous year at constant exchange rates. The average number of shares
outstanding decreased from 5,476,798 to 5,145,619.

The Group's cash at December 31, 2010 exceeded the liabilities to banks and
leasing companies by EUR0.3 million. In the previous year, there was still
net debt in the amount of EUR-0.5 million. The equity ratio further
improved to 72% (previous year: 67%).

UMS expects revenue growth to continue in the current fiscal year 2011,
with consolidated revenues between EUR40 million and EUR42 million. UMS
expects earnings per share to increase to EUR0.60 to EUR0.70.

Given the positive earnings trend, the Management Board and the Supervisory
Board plan to propose to the shareholders' meeting in May 2011 to continue
the dividend payment begun last year and to distribute an increased
dividend of EUR0.50 per share.

UMS AG's annual report can be downloaded in German and English from the
Company's website at www.umsag.com.

UMS AG also announced, that the option agreement valid until March 31, 2011
has been terminated. The holders of the option will not exercise their
subscription rights. The Company granted a cash settlement of kEUR71.


About UMS AG

UMS International AG is a provider of innovative healthcare delivery
concepts in the growth segment of high-tech medicine. UMS pioneered the
mobile deployment of high-class medical systems and markets a comprehensive
range of full-service solutions for hospitals and specialists. The
forward-looking concepts include complete services for the customer,
covering everything from system management to the provision of trained
application specialists. The UMS Group currently has around 200 employees
worldwide and serves over 600 customers.


Contact

Wiebke Budwasch, Tel: (040) 500 177-00, Fax: (040) 500 177-77, E-Mail:
investor@umsag.com


End of Corporate News

---------------------------------------------------------------------

04.04.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English                                               
Company:     UMS United Medical Systems International AG           
             Borsteler Chaussee 53                                 
             22453 Hamburg                                         
             Deutschland                                           
Phone:       +49 (0)40 - 500 177 - 00                              
Fax:         +49 (0)40 - 500 177 - 77                              
E-mail:      investor@umsag.com                                    
Internet:    www.umsag.com                                         
ISIN:        DE0005493654                                          
WKN:         549365                                                
Listed:      Regulierter Markt in Frankfurt (Prime Standard);      
             Freiverkehr in Berlin, Düsseldorf, Hamburg, München,  
             Stuttgart                                             
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
118256 04.04.2011